News

Hello and welcome to Virtual Investor Conferences. On behalf of the Life Sciences Investor Forum and our co-host, Zacks Small Cap Research, we're very pleased you joined us for our quarterly ...
Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).
Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...
Dr. Miller says cleaning your rash once a day is plenty. If you choose to do so in the shower, use lukewarm water; high heat ...
Antiviral medications nirmatrelvir/ritonavir (Paxlovid) were not effective in relieving long COVID symptoms, according to a ...
A novel decentralized clinical trial found that Paxlovid was ineffective in alleviating long COVID symptoms but underscored ...
Researchers had known that there was something odd about the development of MS, and attributed it to the so-called hygiene ...
Infectious diseases are becoming more frequent, more severe, and harder to control in our closely connected world. Viruses ...